Cleiton S. Santos
Oswaldo Cruz Foundation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Cleiton S. Santos.
Infection and Immunity | 2008
Julio Croda; Cláudio Pereira Figueira; Elsio A. Wunder; Cleiton S. Santos; Mitermayer G. Reis; Albert I. Ko; Mathieu Picardeau
ABSTRACT The pathogenic mechanisms of Leptospira interrogans, the causal agent of leptospirosis, remain largely unknown. This is mainly due to the lack of tools for genetically manipulating pathogenic Leptospira species. Thus, homologous recombination between introduced DNA and the corresponding chromosomal locus has never been demonstrated for this pathogen. Leptospiral immunoglobulin-like repeat (Lig) proteins were previously identified as putative Leptospira virulence factors. In this study, a ligB mutant was constructed by allelic exchange in L. interrogans; in this mutant a spectinomycin resistance (Spcr) gene replaced a portion of the ligB coding sequence. Gene disruption was confirmed by PCR, immunoblot analysis, and immunofluorescence studies. The ligB mutant did not show decrease virulence compared to the wild-type strain in the hamster model of leptospirosis. In addition, inoculation of rats with the ligB mutant induced persistent colonization of the kidneys. Finally, LigB was not required to mediate bacterial adherence to cultured cells. Taken together, our data provide the first evidence of site-directed homologous recombination in pathogenic Leptospira species. Furthermore, our data suggest that LigB does not play a major role in dissemination of the pathogen in the host and in the development of acute disease manifestations or persistent renal colonization.
Vaccine | 2008
Éverton Fagonde da Silva; Cleiton S. Santos; Daniel Abensur Athanazio; Núbia Seyffert; Fabiana Kömmling Seixas; Gustavo M. Cerqueira; Michel Quevedo Fagundes; Claudiomar Soares Brod; Mitermayer G. Reis; Odir A. Dellagostin; Albert I. Ko
Effort has been made to identify protective antigens in order to develop a recombinant vaccine against leptospirosis. Several attempts failed to conclusively demonstrate efficacy of vaccine candidates due to the lack of an appropriate model of lethal leptospirosis. The purposes of our study were: (i) to test the virulence of leptospiral isolates from Brazil, which are representative of important serogroups that cause disease in humans and animals; and (ii) to standardize the lethal dose 50% (LD(50)) for each of the virulent strains using a hamster (Mesocricetus auratus) model. Five of seven Brazilian isolates induced lethality in a hamster model, with inocula lower than 200 leptospires. Histopathological examination of infected animals showed typical lesions found in both natural and experimental leptospirosis. Results described here demonstrated the potential use of Brazilian isolates as highly virulent strains in challenge experiments using hamster as an appropriate animal model for leptospirosis. Furthermore these strains may be useful in heterologous challenge studies which aim to evaluate cross-protective responses induced by sub-unit vaccine candidates.
Journal of Medical Microbiology | 2010
Cleiton S. Santos; Júlio O. Macedo; Maurício Bandeira; Adenizar D. Chagas-Junior; Alan J. A. McBride; Flávia W. C. McBride; Mitermayer G. Reis; Daniel Abensur Athanazio
The mouse disease model has the advantage of a broad array of immunological and genetic tools available for basic research. Some studies on transgenic and/or mutant mouse strains as models for experimental leptospirosis have been reported; however, the wider use of such models is hampered by a poor understanding of the outcome of experimental leptospiral infection among the different mouse strains available. Here, the outcome of infection by a virulent strain of Leptospira interrogans serogroup Icterohaemorrhagiae strain Cop was studied in four commonly used wild-type mouse strains: A, CBA, BALB/c and C57BL/6. The end points evaluated in this study were survival, presence of kidney lesions, leptospiral load in kidney samples, microscopic agglutination test titre and anti-leptospiral IgG antibody levels. As expected, none of the mouse strains were susceptible to lethal leptospirosis. However, these strains developed specific pathologies associated with sublethal leptospirosis. The A and C57BL/6 strains exhibited a high leptospiral load in kidney samples and the CBA and C57BL/6 strains developed severe inflammatory lesions, whilst the BALB/c strain proved to be the most resistant to subclinical leptospirosis.
Infection and Immunity | 2011
Maurício Bandeira; Cleiton S. Santos; Everton Cruz de Azevedo; Luciane Marieta Soares; Júlio O. Macedo; Samyra Marchi; Caroline Luane R. da Silva; Adenizar D. Chagas-Junior; Alan J. A. McBride; Flávia W. C. McBride; Mitermayer G. Reis; Daniel Abensur Athanazio
ABSTRACT The aims of this study were to investigate the frequency of pulmonary hemorrhage (PH) in mice unable to produce functional B and T lymphocytes and to explore the effect of an inducible nitric oxide synthase gene (Inos) knockout (KO) on the frequency/severity of interstitial nephritis in vivo. We studied the outcome of infection by the virulent Leptospira interrogans serovar Copenhageni strain Cop. The animals used were Inos KO mice, recombination activating gene 1 (Rag1) KO mice, CB17 severe combined immunodeficiency (SCID) mice, and the respective wild-type (WT) C57BL/6 and BALB/c controls. The Inos KO and WT mice survived with no clinical symptoms of leptospirosis. The frequency and severity of nephritis was significantly lower in the Inos KO mice. All of the Rag1 KO and SCID animals died of acute leptospirosis, whereas all of the WT mice survived. PH was observed in 57 and 94% of Rag1 KO mice and in 83 and 100% of SCID mice, using inoculum doses of 107 and 106 leptospires, respectively. There was no evidence of PH in the WT controls. In conclusion, the loss of the Inos gene had a negligible effect on the outcome of leptospiral infection, although we observed a reduced susceptibility for interstitial nephritis in this group. Of note, the absence of functional B- and T-cell lymphocytes did not preclude the occurrence of PH. These data provide evidence that PH in leptospirosis may not be related only to autoimmune mechanisms.
PLOS Neglected Tropical Diseases | 2017
Neida Lucia Conrad; Flávia W. Cruz McBride; Jéssica Dias Souza; Marcelle Moura Silveira; Samuel Rodrigues Felix; Karla S. Mendonça; Cleiton S. Santos; Daniel Abensur Athanazio; Marco Alberto Medeiros; Mitermayer G. Reis; Odir A. Dellagostin; Alan J. A. McBride
Neglected tropical diseases, including zoonoses such as leptospirosis, have a major impact on rural and poor urban communities, particularly in developing countries. This has led to major investment in antipoverty vaccines that focus on diseases that influence public health and thereby productivity. While the true, global, impact of leptospirosis is unknown due to the lack of adequate laboratory diagnosis, the WHO estimates that incidence has doubled over the last 15 years to over 1 million cases that require hospitalization every year. Leptospirosis is caused by pathogenic Leptospira spp. and is spread through direct contact with infected animals, their urine or contaminated water and soil. Inactivated leptospirosis vaccines, or bacterins, are approved in only a handful of countries due to the lack of heterologous protection (there are > 250 pathogenic Leptospira serovars) and the serious side-effects associated with vaccination. Currently, research has focused on recombinant vaccines, a possible solution to these problems. However, due to a lack of standardised animal models, rigorous statistical analysis and poor reproducibility, this approach has met with limited success. We evaluated a subunit vaccine preparation, based on a conserved region of the leptospiral immunoglobulin-like B protein (LigB(131–645)) and aluminium hydroxide (AH), in the hamster model of leptospirosis. The vaccine conferred significant protection (80.0–100%, P < 0.05) against mortality in vaccinated animals in seven independent experiments. The efficacy of the LigB(131–645)/AH vaccine ranged from 87.5–100% and we observed sterile immunity (87.5–100%) among the vaccinated survivors. Significant levels of IgM and IgG were induced among vaccinated animals, although they did not correlate with immunity. A mixed IgG1/IgG2 subclass profile was associated with the subunit vaccine, compared to the predominant IgG2 profile seen in bacterin vaccinated hamsters. These findings suggest that LigB(131–645) is a vaccine candidate against leptospirosis with potential ramifications to public and veterinary health.
PLOS ONE | 2012
Adenizar D. Chagas-Junior; Caroline Luane Rabelo da Silva; Luciane Marieta Soares; Cleiton S. Santos; Carlos D. C. M. Silva; Daniel Abensur Athanazio; Mitermayer G. Reis; Flávia Weykamp da Cruz McBride; Alan J. A. McBride
A major limitation in the clinical management and experimental research of leptospirosis is the poor performance of the available methods for the direct detection of leptospires. In this study, we compared real-time PCR (qPCR), targeting the lipL32 gene, with the immunofluorescent imprint method (IM) for the detection and quantification of leptospires in kidney samples from the rat and hamster experimental models of leptospirosis. Using a virulent strain of Leptospira interrogans serovar Copenhageni, a chronic infection was established in the rat model, which were euthanized 28 days post-infection, while the hamster model simulated an acute infection and the hamsters were euthanized eight days after inoculation. Leptospires in the kidney samples were detected using culture isolation, qPCR and the IM, and quantified using qPCR and the IM. In both the acute and chronic infection models, the correlation between quantification by qPCR and the IM was found to be positive and statistically significant (P<0.05). Therefore, this study demonstrates that the IM is a viable alternative for not only the detection but also the quantification of leptospires, particularly when the use of qPCR is not feasible.
Transactions of The Royal Society of Tropical Medicine and Hygiene | 2014
Luciane Marieta Soares; Júlio O. Macedo; Everton Cruz de Azevedo; Cleiton S. Santos; Marina de Queiroz Sampaio; Andréia C. Santos; Mitermayer G. Reis; Daniel Abensur Athanazio
BACKGROUND The benefit of antibiotics in leptospirosis is limited when treatment is started four days after symptoms appear, and new adjuvant therapeutic options are urgently needed. METHODS Hamsters (Mesocricetus auratus) were infected by Leptospira interrogans strain L1-130, and groups were assigned based on no treatment (NONE), thalidomide only (TAL), ampicillin only (AMP) or both (AMP-TAL). Treatment was started two days after the onset of symptoms (experiment 1) and immediately after detection of the first death (experiment 2). RESULTS Experiment 1: all hamsters from the groups AMP and AMP-TAL survived (n=8), while all hamsters from groups NONE (n=6) and TAL (n=8) died. The AMP and the AMP-TAL groups showed no renal or liver pathology and absent or very low leptospiral burden in target organs. Experiment 2: lethal outcome was observed in 6/6 hamsters in the NONE group, 8/8 in the TAL group, and 6/8 in both the AMP and AMP-TAL groups. Thalidomide showed no survival benefit when compared to hamsters treated with ampicillin alone. The TAL, AMP and AMP-TAL groups had very low tissue leptospiral counts. CONCLUSION Thalidomide had minimal impact on survival in the late treatment of leptospirosis hamster model.
Journal of the Neurological Sciences | 2018
Mateus Santana do Rosário; Pedro Antonio Pereira de Jesus; Daniel Santana Farias; Marco Antonio Novaes; Cleiton S. Santos; Sasha R. Azar; Nikos Vasilakis; Daniel Lima de Moura; Fernanda Washington de Mendonça Lima; Luiz Carlos Junior Alcantara; Isadora Siqueira
NIH grants R24AI120942 and 1U01AI115577 (NV) and MCTI/FINEP/FNDCT-Brazil grant 04160060- 00/2016 (LCJA)
International Journal of Infectious Diseases | 2018
Breno Lima de Almeida; J. Cabral; Adriana Virginia Barros Faiçal; J.V. Oliveira; Marco Tulio Souza; C. Salles; M. I Vianna; E D’Agostino; N. Ferreira; L. Reis; E. Embiruçu; Cleiton S. Santos; A Duarte; A. Acosta; Isadora Siqueira
Background: Discordant clinical outcomes in congenital infectious disorders have been described, such as in Cytomegalovirus, toxoplasmosis and HIV infection, most of then in dizygotic twin pregnancies. In Brazil, since 2015, more than 2800 cases of congenital Zika infection (CZI) were confirmed. To date, three cases of discordant CZI infection in twins were reported, one case in monozygotic pregnancy and two cases in dizygotic twin pregnancies. Methods & Materials: Here, we describe a case report with the clinical presentation of discordant twin siblings, one with microcephaly
Vaccine | 2007
Éverton Fagonde da Silva; Marco Alberto Medeiros; Alan J. A. McBride; Jim Matsunaga; Gabriela dos Santos Esteves; João Gabriel Rosa Ramos; Cleiton S. Santos; Julio Croda; Akira Homma; Odir A. Dellagostin; David A. Haake; Mitermayer G. Reis; Albert I. Ko